Journal
JOURNAL OF IMMUNOLOGY
Volume 197, Issue 6, Pages 2362-2368Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1502268
Keywords
-
Categories
Funding
- National Institutes of Health [P01GM095467, R01GM38765]
- Arthritis Foundation
- Arthritis Research UK Carrier Development Fellowship [19909]
- Wellcome Trust [107613/Z/15/Z]
- Royal Society [107613/Z/15/Z]
- Versus Arthritis [19909] Funding Source: researchfish
Ask authors/readers for more resources
Uncontrolled inflammation is a unifying component of many chronic inflammatory diseases, such as arthritis. Resolvins (Rvs) are a new family from the endogenous specialized proresolving mediators (SPMs) that actively stimulate resolution of inflammation. In this study, using lipid mediator metabololipidomics with murine joints we found a temporal regulation of endogenous SPMs during self-resolving inflammatory arthritis. The SPMs present in self-resolving arthritic joints include the D-series Rvs, for example, RvD1, RvD2, RvD3, and RvD4. Of note, RvD3 levels were reduced in inflamed joints from mice with delayed-resolving arthritis when compared with self-resolving inflammatory arthritis. RvD3 was also reduced in serum from rheumatoid arthritis patients compared with healthy controls. RvD3 administration reduced joint leukocytes as well as paw joint eicosanoids, clinical scores, and edema. Taken together, these findings provide evidence for dysregulated endogenous RvD3 levels in inflamed paw joints and its potent actions in reducing murine arthritis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available